A Rhodamine Appended Iron-Recognizing Probe for On-Demand Theranostics in Anemic Drosophila
Inorganic Chemistry · 2026
DOI: 10.1021/acs.inorgchem.6c00293 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inorganic Chemistry, 2026. Verfasst von Debadutta Samal und 11 weiteren Autor:innen. Beteiligte Einrichtung: Future Materials Laboratory, Department of Chemistry, School of Applied Sciences, Kalinga Institute of Industrial Technology (KIIT) Deemed to be Univ…. Hauptthemen laut MEDLINE: Rhodamines, Fluorescent Dyes, Iron, Theranostic Nanomedicine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Department of Atomic Energy, Government of India.
Abstract (Originalsprache)
The development of functional organic molecules for advanced biological and environmental applications is of growing interest, particularly for metal ion sensing and therapeutic delivery. Rhodamine-based fluorescent compounds have been widely studied due to their well-defined absorption and emission properties. In this study, a rhodamine-appended fluorescent probe (RhB-A) was designed and synthesized, exhibiting strong fluorescence upon excitation at 400 nm. The probe demonstrates exceptional selectivity for Fe3+ ions, with significant fluorescence quenching even in the presence of 16 competing metal ions, with a LOD of 0.285 ppm in a semiaqueous medium, below the WHO guideline for iron in drinking water. Further, the Fe3+-coordinated complex was isolated as single crystals, confirming a 1:2 metal-to-ligand binding ratio. UV-Vis absorption studies further verified a reversible binding mechanism, supporting the probe's potential as a reusable sensor. Computational studies supported the ligand's reactivity and bioactivity, consistent with its experimental selectivity as a sensor. Importantly, the Fe3+ complex effectively treated lead-induced anemia in Drosophila melanogaster, delivering iron to deficient cells in a controlled and targeted manner. Thus, the designed fluorescent probe and its Fe3+ complex exhibited dual potential as a selective Fe3+ sensor and an anemia treatment agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Future Materials Laboratory, Department of Chemistry, School of Applied Sciences, Kalinga Institute of Industrial Technology (KIIT) Deemed to be University, Bhubaneswar, Odisha 751024, India.
- Department of Life Science, National Institute of Technology Rourkela, Rourkela, Sundargarh, Odisha 769008, India.
- Department of Chemistry & Center of Advanced Studies in Chemistry, Panjab University, Chandigarh 160014, India.
- Department of Chemistry, Indian Institute of Technology Kanpur, Kanpur 208016, India.
- Center for Next Generation Materials and Technology, Kalinga Institute of Industrial Technology (KIIT) Deemed to be University, Bhubaneswar, Odisha 751024, India.
ORCID-Profile: Venkateswara Rao Mundlapati, Basudeb Dutta, Rojalin Sahu
Förderung
- Department of Atomic Energy, Government of India
Zitieren
APA
Samal, D., Hembram, M., Mishra, L., Priyadarshini, A., Panda, S. P., Sahoo, S. C., Pramanik, S., Manna, S., Mundlapati, V. R., Dutta, B., Mishra, M., & Sahu, R. (2026). A Rhodamine Appended Iron-Recognizing Probe for On-Demand Theranostics in Anemic Drosophila. Inorganic Chemistry. https://doi.org/10.1021/acs.inorgchem.6c00293
Vancouver
Samal D, Hembram M, Mishra L, Priyadarshini A, Panda SP, Sahoo SC, et al. A Rhodamine Appended Iron-Recognizing Probe for On-Demand Theranostics in Anemic Drosophila. Inorganic Chemistry. 2026. doi:10.1021/acs.inorgchem.6c00293
BibTeX
@article{Samal2026,
author = {Samal, Debadutta and Hembram, Madhuri and Mishra, Lokanath and Priyadarshini, Anulipsa and Panda, Swasti Padma and Sahoo, Subash Chandra and Pramanik, Subhadip and Manna, Santanu and Mundlapati, Venkateswara Rao and Dutta, Basudeb and Mishra, Monalisa and Sahu, Rojalin},
title = {A Rhodamine Appended Iron-Recognizing Probe for On-Demand Theranostics in Anemic Drosophila},
journal = {Inorganic Chemistry},
year = {2026},
doi = {10.1021/acs.inorgchem.6c00293}
}
EUVIMED